GoldenGolden
Advanced Search
OS Fund

OS Fund

A venture capital and private equity firm commercializing discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development.

OS Fund is a venture capital and private equity firm commercializing discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development that is headquartered in Park Ridge, Illinois and was founded in 2014 by Bryan Johnson, Jeff Klunzinger, and Jeffrey Klunzinger. Notable investments made by OS Fund include: Catalog, Ginkgo Bioworks, Arzeda, Elysium, Emerald Therapeutics, JUST Foods, Synthetic Genomics, Verge Genomics, and Truvian.

OS Fund was founded by Bryan Johnson in 2014, personally funding the venture capital with $100m.

OS Fund I

OS Fund I made 28 investments, with 27 receiving follow on investment, four valued at over a billion dollars, and two were acquired. OS Fund invested in entrepreneurs using applied intelligence in genomics, synthetic biology, diagnostics, new materials, and data and energy.

OS Fund II

On August 7, 2018 OS Fund announced raising $250 million in capital for their OS Fund II investment fund. At the time of the company's OS Fund II announcement, OS Fund also announced that it has already invested $24.9 million (10% of the capital of OS Fund II) into three technology companies; Arzeda, NuMat Technologies, and UBiome.

Timeline

Funded Companies

Associated investment funds

People

Name
Role
LinkedIn

Bryan Johnson

Co-founder

Jeff Klunzinger

Co-founder

Further reading

Title
Author
Link
Type
Date

OS Fund -- Building A Global Biological Immune System

Bryan Johnson

Web

OS Fund Raising $250M to Support Entrepreneurs Building Deep Tech to Solve Global Problems

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Augmenta Bioworks

Catalog

Cleversafe

Elysium

Emulate

Human Longevity Project

Matternet

Miroculus

Nanoly Bioscience

NuMat Technologies

Pivot BIo

Planetary Resources

Plethora

Prospect Bio

Sythego

Sythetic Genomics

Tempo Automation

Page 1 of 2

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.